Atypical chronic lung disease in preterm infants

Jayachandran Panickar1, Helen Scholefield, Yadlapalli Kumar

  • 1Neonatal Intensive Care Unit, Liverpool Women's Hospital, Liverpool, UK.

Insights

Atypical chronic lung disease (CLD) is common in preterm infants, affecting larger, more mature babies. This study found no link between intrauterine inflammation and atypical CLD development.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Perinatal Medicine

Background:

  • Chronic lung disease (CLD) is a significant complication in preterm infants.
  • An atypical pattern of CLD has been observed, with a proposed link to intrauterine inflammation.
  • Understanding CLD patterns and associated perinatal factors is crucial for improving infant respiratory outcomes.

Purpose of the Study:

  • To describe patterns of CLD in preterm infants.
  • To determine the incidence of atypical CLD.
  • To compare perinatal factors in infants with classic versus atypical CLD.

Main Methods:

  • Retrospective chart review of neonatal admissions with birthweight <1250 g.
  • CLD defined as oxygen dependency at 28 days of age.
  • Classification of CLD into classic and atypical patterns based on defined criteria.

Main Results:

  • CLD developed in 51% of survivors at 28 days; 41% of these were classified as atypical CLD.
  • Factors associated with atypical CLD included being inborn, receiving natural surfactant, fewer mechanical ventilation days, and higher birthweight.
  • No significant association was found between atypical CLD and chorioamnionitis, postnatal infection, or symptomatic patent ductus arteriosus (PDA).

Conclusions:

  • Atypical CLD is a common presentation of prolonged oxygen dependency in preterm survivors.
  • Atypical CLD is associated with larger, more mature infants.
  • The findings do not support intrauterine inflammation as a primary etiological factor for atypical CLD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.